Century Therapeutics (IPSC) Preferred Shares (2020)

Century Therapeutics' (IPSC) quarterly Preferred Shares came in at $144.8 million in Q4 2020.

Century Therapeutics (IPSC) Preferred Shares (2020) Analysis & Trends

Century Therapeutics (IPSC) has 1 years of Preferred Shares data on file, last reported at $144.8 million in Q4 2020.

On a quarterly basis, Preferred Shares changed N/A year-over-year to $144.8 million in Q4 2020; TTM through Dec 2020 was $144.8 million, a N/A change from a year earlier, with the FY2020 full-year figure at $144.8 million, changed N/A from the prior year.
Preferred Shares for Q4 2020 stood at $144.8 million.
Over the last five years, Preferred Shares for IPSC reached as high as $144.8 million in Q4 2020 and fell as low as $144.8 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Century Therapeutics	406.30 Mn	271.49 Mn	-	-

Download Data

Date	Value
Dec 31, 2020	144.84 Mn